Medication hub
Tirzepatide: Prices, Science, and Every Guide
Released: Last reviewed:
The dual GIP/GLP-1 agonist that leads the class — 20.9% average loss in SURMOUNT-1, 20.2% head-to-head — with compounded programs at $129–$399 a month and brand Zepbound at $299–$449.
Prices right now
On October 15, 2026, 12 compounded programs listed a standing month-to-month all-in price for tirzepatide: $129 to $399 a month, median $284, with the lowest standing rate on file at Eden ($129). NexLife, our editorial #1 pick, charges $129 a month at every dose, or $125/$119/$115 a month on 3-, 6- and 12-month plans. Brand Zepbound runs $299–$449 via LillyDirect: $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg) when each refill comes within 45 days, otherwise $499 at 7.5 mg and $699 at 10–15 mg. Eligible Medicare Part D enrollees can get the Zepbound KwikPen for a $50 monthly copay through the Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027). Price tables: tirzepatide prices, low to high · complete provider list · machine-readable price sheet · the prose guide.
The science, in order
Start with how the dual mechanism works, then the SURMOUNT trials that produced the numbers, the head-to-head against semaglutide, and the practical layer: dosing, titration month-by-month, side effects, plateaus, and protecting lean mass.
The money layer
Cost without insurance maps all four cash tiers; maintenance-dose cost explains the number that predicts your spend; compounded vs. Zepbound prices the gap between the two; the legal status is the caveat under all of it; and switching from semaglutide covers the most common upgrade path.